ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

29,986Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 2680

$1.51M Total Retail Price of All Prescriptions

Rank: 16 out of 2680

845 Patients Receiving at Least One Drug in Part D
83%Patients 65 Years and Older
84% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 845 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

11% of this provider’s 845 patients filled at least one prescription for a schedule three drug, compared to an average of 6%.

Risky Drugs to Seniors

1% of this provider’s 24,682 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $67 among peers.

Prescriptions per Patient

35 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
LISINOPRIL 1,311 1,039 1 5
WARFARIN SODIUM 1,202 1,106 2 12
SIMVASTATIN 1,120 892 3 1
OMEPRAZOLE 1,072 862 4 2
FUROSEMIDE 1,023 928 5 7
LEVOTHYROXINE SODIUM 1,013 867 6 4
METOPROLOL TARTRATE 937 801 7 8
AMLODIPINE BESYLATE 725 626 8 3
SERTRALINE HCL 687 621 9 23
METFORMIN HCL 673 521 10 6
DONEPEZIL HCL 549 523 11 28
POTASSIUM CHLORIDE 485 450 12 29
MIRTAZAPINE 420 404 13 48
GLIPIZIDE 334 254 14 71
TAMIFLU 317 285 10 15 136
GEMFIBROZIL 311 211 16 119
CARVEDILOL 307 241 17 27
TAMSULOSIN HCL 299 240 18 25
HYDROCHLOROTHIAZIDE 297 262 19 9
HYDROCODONE-ACETAMINOPHEN 297 244 S3 19 13
PRAVASTATIN SODIUM 293 251 21 16
GABAPENTIN 286 252 22 21
IPRATROPIUM-ALBUTEROL 281 272 23 110
MELOXICAM 278 252 24 50
NAMENDA 269 258 25 43
ATENOLOL 269 258 25 14
CITALOPRAM HBR 254 236 27 22
POLYETHYLENE GLYCOL 3350 243 159 28 55
CLOPIDOGREL 242 206 29 30
CARBIDOPA-LEVODOPA 240 216 30 88
ATORVASTATIN CALCIUM 233 131 31 10
SPIRIVA 223 140 32 36
METOPROLOL SUCCINATE 215 188 33 11
OXYBUTYNIN CHLORIDE ER 190 137 34 135
RISPERIDONE 183 156 35 67
QUETIAPINE FUMARATE 176 147 36 72
CLOTRIMAZOLE-BETAMETHASONE 169 161 37 109
LOSARTAN POTASSIUM 167 142 38 18
PLAVIX 163 138 39 41
RANITIDINE HCL 157 120 40 35
FAMOTIDINE 157 109 40 65
CYMBALTA 153 130 42 56
CLONIDINE HCL 153 128 42 84
ALLOPURINOL 151 129 44 42
FENOFIBRATE 142 25 45 77
HYDRALAZINE HCL 135 114 46 99
ROPINIROLE HCL 134 112 47 143
DOXYCYCLINE HYCLATE 133 124 48 237
TRAMADOL HCL 131 120 49 33
LEVETIRACETAM 128 81 50 94
NOVOLIN R 125 112 51 210
DIOVAN 125 115 51 26
PREDNISONE 123 102 53 45
FLUTICASONE PROPIONATE 122 91 54 38
PERMETHRIN 119 96 55 307
ESCITALOPRAM OXALATE 111 106 56 82
NEXIUM 109 96 57 19
DIGOXIN 107 106 58 59
KLOR-CON M20 107 102 58 101
JANUVIA 106 99 60 34
ADVAIR DISKUS 106 103 60 32
ZOLPIDEM TARTRATE 106 73 60 17
TORSEMIDE 105 96 63 169
PAROXETINE HCL 104 104 64 62
SPIRONOLACTONE 102 53 65 86
LIDODERM 100 86 66 74
ALENDRONATE SODIUM 98 84 67 20
ALBUTEROL SULFATE 97 70 68 97
BISOPROLOL FUMARATE 93 73 69 163
LATANOPROST 91 70 70 195
FLUOCINONIDE 90 73 71 211
ISOSORBIDE MONONITRATE ER 90 79 71 57
HYDROXYZINE HCL 86 77 R 73 212
RAMIPRIL 83 70 74 49
LISINOPRIL-HYDROCHLOROTHIAZIDE 82 58 75 31
FINASTERIDE 81 69 76 80
BACLOFEN 79 52 77 123
ISOSORBIDE DINITRATE 79 79 77 298
NOVOLIN 70-30 77 68 79 277
PHENYTOIN SODIUM EXTENDED 76 56 80 207
SULFAMETHOXAZOLE-TRIMETHOPRIM 75 66 81 137
PANTOPRAZOLE SODIUM 73 71 82 44
SUCRALFATE 72 53 83 269
BENZTROPINE MESYLATE 72 41 R 83 193
NYSTATIN 71 48 85 160
PRADAXA 68 67 86 203
FLUOXETINE HCL 68 52 86 76
PROAIR HFA 68 52 86 52
AZITHROMYCIN 67 55 89 40
LANTUS 67 56 89 70
MUPIROCIN 65 48 91 152
BUSPIRONE HCL 62 62 92 174
TRICOR 61 23 93 115
FENTANYL 61 43 S2 93 102
OLANZAPINE 60 54 95 128
CIPROFLOXACIN HCL 59 52 96 85
ENALAPRIL MALEATE 59 49 96 24
GLIMEPIRIDE 59 31 96 51
BUDESONIDE 58 53 99 299
MECLIZINE HCL 57 40 100 105
ZETIA 57 44 100 69
CRESTOR 57 49 100 15
VERAPAMIL ER 57 57 100 126
TRAZODONE HCL 57 41 100 60
VENLAFAXINE HCL 57 20 100 305
HUMALOG 56 41 106 246
CEPHALEXIN 56 50 106 132
SEROQUEL 55 48 108 161
LACTULOSE 55 47 108 100
COMBIVENT 55 38 108 129
KLOR-CON M10 55 43 108 185
CELEBREX 53 45 112 75
SYMBICORT 53 47 112 114
LOVAZA 52 24 114 47
CLOTRIMAZOLE 51 46 115 268
KLOR-CON 10 51 0 115 177
FLOVENT HFA 50 40 117 230
SANTYL 50 46 117 144
DIVALPROEX SODIUM 50 46 117 90
HYDROXYZINE PAMOATE 50 42 R 117 471
OXYBUTYNIN CHLORIDE 50 36 117 189
DILTIAZEM HCL 50 36 117 324
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 11, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.